Enovis raises FY25 adjusted EPS view to $3.10-$3.25 from $3.05-$3.20

FY25 consensus $3.13. Enovis (ENOV) updated financial expectations for 2025. Revenue is expected to be in the range of $2.24-2.27 billion, versus prior expectations of $2.245-2.275 billion. Updated guidance includes a $15 million revenue reduction attributable to the Dr. Comfort divestiture completed in October 2025. Adjusted EBITDA is forecasted to be $395-405 million, as compared to the prior outlook of $392-402 million. Full-year adjusted earnings per share guidance was updated from $3.05-3.20 to $3.10-3.25.